Table 2.

 Clinical features of the 12 patients who were positive for human coronavirus NL63

Sample number	Date of collection	Gender	Age	Underlying conditions	Symptoms	Physical examination findings	Other information	Discharge diagnosis
10614	040127	M	3 weeks	None	Rhinitis, dyspnoea	No focus of infection		Upper respiratory tract infection
25188	041222	M	3 weeks	None	Rhinitis, dyspnoea, vomiting	Crepitations, rhonchi	Adrenaline inhalations	Bronchiolitis
25190	041222	M	1 month	None	Rhinitis, dyspnoea	Tachypnoea, crepitations, pharyngitis	Adrenaline inhalations	Bronchiolitis
25205	041226	M	2 months	None	Dyspnoea, fever, apathy	Crepitations, rhonchi, rash	Adrenaline inhalations	Viral infection
25222	041228	F	3 months	None	Rhinitis, fever	Fever		Upper respiratory tract infection
25230	041230	M	3 months	None	Rhinitis, cough, secretion from right eye	Bell's palsy, right side	Onset of palsy probably weeks before rhinitis	Upper respiratory tract infection, Bell's palsy
36024	050105	F	4 months	None	Dyspnoea, vomiting	Crepitations		Upper respiratory tract infection
36031	050110	M	2 months	Pre‐term week 28, RDS	Apathy, cough, dyspnoea	Pale, dehydrated	CXR: bilateral apical infiltrates, CPAP ventilation	Upper respiratory tract infection
36089	050120	F	4 months	None	Cough, dyspnoea	Tachypnoea, crepitations		Upper respiratory tract infection
36116	050131	M	1 month	None	Vomiting, cough	No focus of infection	Hospitalisation for pylorostenosis	Pylorostenosis, upper respiratory tract infection
36150	050207	M	4 weeks	None	Rhinitis, dyspnoea	Pharyngitis, fever		Upper respiratory tract infection
36164	050210	F	2 years	Pre‐term week 24, RDS, repeated asthmatic bronchiolitis	Dyspnoea, insufficient effect of asthma medication	Crepitations, rhonchi	CXR: unilateral basal infiltrate, co‐infection with hMPV	Asthma, infection triggered

RDS, respiratory distress syndrome; CXR, chest X‐ray; CPAP, continuous positive airways pressure; hMPV, human metapneumovirus.